Product image of Monovo (Mometasone Furoate) supplied by GNH India

Monovo

Active Ingredient:
Mometasone Furoate
Origin:
EU

Monovo (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Monovo, is a corticosteroid presented as a topical formulation for skin use. It is prescribed to reduce inflammation and relieve symptoms in various dermatologic conditions such as atopic dermatitis, psoriasis, seborrheic dermatitis and contact dermatitis.

GNH India supplies Monovo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. It holds regulatory approvals across multiple regions, ensuring consistent product availability.

Manufacturer / TM Owner

Almirall Hermal Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone Furoate is used topically to manage inflammatory skin disorders.

  • Atopic dermatitis: reduces inflammation, itching and scaling associated with the condition.
  • Psoriasis: decreases plaque formation and erythema in affected areas.
  • Seborrheic dermatitis: controls redness and flaking on the scalp and face.
  • Contact dermatitis: alleviates allergic skin reactions and irritation.

How It Works

  • Mometasone Furoate exerts its anti‑inflammatory and immunosuppressive effects by binding to intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it modulates gene transcription, suppressing pro‑inflammatory cytokines, chemokines and adhesion molecules. This results in reduced infiltration of inflammatory cells, decreased edema and inhibition of keratinocyte proliferation, providing symptomatic relief in dermatologic conditions.

Side Effects

Topical application of Mometasone Furoate may be associated with local adverse reactions.

Common Side Effects

  • Burning sensation at the application site.
  • Itching or mild irritation.
  • Dryness or peeling of the skin.
  • Redness or erythema.
  • Folliculitis or acneiform eruptions.

Serious or Rare Side Effects

  • Skin atrophy or thinning with prolonged use.
  • Hypopigmentation or discoloration of treated areas.
  • Secondary bacterial, fungal or viral infection.
  • Systemic corticosteroid effects such as adrenal suppression.
  • Allergic contact dermatitis or severe hypersensitivity reaction.

Precautions & Warnings

When prescribing or using Monovo, several precautions should be observed to minimize risks.

  • Duration of treatment: limit use to the shortest period necessary to control symptoms.
  • Application area: avoid extensive or occlusive coverage, especially on large body surface areas.
  • Infected skin: do not apply on active bacterial, fungal or viral skin infections.
  • Children: use with caution in pediatric patients, monitoring for growth‑related effects.
  • Pregnancy and lactation: safety has not been established; assess risk versus benefit.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Mometasone Furoate may interact with other agents, influencing efficacy or safety.

Major Interactions (Avoid)

  • Concurrent systemic corticosteroids: may increase risk of systemic side effects such as adrenal suppression.
  • Live vaccines: topical steroid use can diminish immune response to vaccination.

Moderate Interactions (Monitor Closely)

  • Antifungal or antibacterial topical agents: may alter skin barrier and affect absorption.
  • Other topical corticosteroids: combined use can enhance local adverse effects.
  • CYP3A4 inhibitors applied to the same area: potential increase in local drug concentration.

Frequently Asked Questions

Monovo, containing Mometasone Furoate, is prescribed for several inflammatory skin disorders. It is commonly used to manage atopic dermatitis, psoriasis, seborrheic dermatitis and contact dermatitis, helping to reduce redness, swelling, itching and scaling associated with these conditions.

Mometasone Furoate works by binding to glucocorticoid receptors inside skin cells. This binding alters gene expression, suppressing the production of inflammatory cytokines and chemokines, and decreasing the migration of immune cells to the skin. The result is reduced inflammation and relief of dermatologic symptoms.

The specific dosing regimen for Monovo is determined by the prescribing healthcare professional. Typically, a thin layer is applied to the affected skin once or twice daily, following the physician’s instructions regarding treatment duration and the amount to use.

Safety data for Mometasone Furoate in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing Monovo to pregnant or nursing individuals, and discuss any concerns with the patient.

To order Monovo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monovo (Mometasone Furoate) is classified as a mid‑ to high‑potency topical corticosteroid, offering stronger anti‑inflammatory activity than low‑potency agents such as hydrocortisone. Compared with very high‑potency steroids, it provides a balance of efficacy and safety, making it suitable for moderate to severe inflammatory dermatoses.

Monovo should be stored at room temperature, preferably below 25 °C, in its original packaging. Keep the product away from excess moisture and direct sunlight. Ensure the container is tightly closed when not in use to maintain product stability.

Apply a thin layer of Monovo to clean, dry skin in the affected area. Gently rub the cream or ointment until it is evenly distributed. Avoid contact with eyes, mucous membranes and open wounds unless directed by a healthcare professional.

Serious risks associated with prolonged or inappropriate use of Monovo include skin atrophy (thinning), hypopigmentation, secondary bacterial, fungal or viral infections, and systemic effects such as adrenal suppression. Patients should report any unusual skin changes or systemic symptoms to their clinician promptly.

Monovo should not be used by individuals with a known hypersensitivity to Mometasone Furoate or any excipients in the formulation. It is also contraindicated on untreated bacterial, fungal or viral skin infections, and should be used with caution in children and in areas of thin skin unless specifically advised by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT